EUVIMEDEUVIMED entdecken
Crossref

Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia

Anja H Schiemann, Sophie M Burling, Remai Allen, Terasa Bulger, Roslyn G Machon, Margaret Perry, Neil Street, Luuk R van den Bersselaar, Kathryn M Stowell

British Journal of Anaesthesia · 2026-01 · 136 (1) · 326-332

DOI: 10.1016/j.bja.2025.10.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2026-01. Verfasst von Anja H Schiemann und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Technology and Natural Sciences, Massey University, Palmerston North, New Zealand. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Ryanodine Receptor Calcium Release Channel, Genetic Predisposition to Disease, Genetic Variation. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Australian and New Zealand College of Anaesthetists, Maurice and Phyllis Paykel Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Muscle biopsy and in vitro contracture testing remain the gold standard for presymptomatic diagnosis of malignant hyperthermia susceptibility. DNA analysis can be used when a familial variant is classified as pathogenic or likely pathogenic. For this, variants must meet a range of criteria, one of which is functional analysis in an approved system that demonstrates hypersensitivity of calcium release when exposed to an appropriate agonist. METHODS: Seven patients with a clinical history of malignant hyperthermia were screened for the presence of variants in RYR1 by amplicon or whole exome sequencing. Six variants in RYR1 were subsequently introduced into the cDNA encoding the human ryanodine receptor and tested in human embryonic kidney cells for their effect on calcium release from intracellular stores in response to 4-chloro-m-cresol using fura-2 as a calcium indicator. Each variant was subjected to in silico curation using the European Malignant Hyperthermia Group (EMHG) scoring matrix and ClinGen RYR1 Variant Curation Expert Panel guidelines. RESULTS: All six RYR1 variants studied (p.Gln464Lys, p.Asp2431Val, p.Val2354Met, p.Ser2542Asn, p.Val2627Leu, and p.Pro4973Leu) were hypersensitive to 4-chloro-m-cresol. Using the EMHG scoring matrix, four variants (p.Gln464Lys, p.Asp2431Val, p.Val2354Met, and p.Val2627Leu) were reclassified as pathogenic, one variant (p.Pro4973Leu) was upgraded from likely pathogenic to pathogenic, and one variant (p.Ser2542Asn) remained as 'uncertain significance'. CONCLUSIONS: Four additional RYR1 variants can be added to the list of RYR1 disease-associated variants managed by the EMHG and can therefore be used diagnostically in the future. One variant can be upgraded from likely pathogenic to pathogenic, whereas one remains as a variant of unknown significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Malignant HyperthermiaRyanodine Receptor Calcium Release ChannelGenetic Predisposition to DiseaseGenetic VariationHumansNew ZealandMaleFemaleAustraliaAdultMiddle AgedHEK293 CellsCresolsCalcium

Stichwörter der Autor:innen

calcium releasemalignant hyperthermiapathogenicitypresymptomatic diagnosisryanodine receptor

Substanzen

Ryanodine Receptor Calcium Release ChannelRYR1 protein, humanCresolsCalcium

Autor:innen und Institutionen

  • School of Food Technology and Natural Sciences, Massey University, Palmerston North, New Zealand.
  • Department of Anaesthesia and Intensive Care, Palmerston North Hospital, Palmerston North, New Zealand.
  • The Children's Hospital Westmead, Sydney, Australia.
  • Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands; Malignant Hyperthermia Investigation Unit, Department of Anesthesiology, Canisius Wilhelmina Hosp…
  • School of Food Technology and Natural Sciences, Massey University, Palmerston North, New Zealand. Electronic address: K.M.Stowell@massey.ac.nz.

Förderung

  • Australian and New Zealand College of Anaesthetists
  • Maurice and Phyllis Paykel Trust

Zitieren

APA

Schiemann, A. H., Burling, S. M., Allen, R., Bulger, T., Machon, R. G., Perry, M., Street, N., van den Bersselaar, L. R., & Stowell, K. M. (2026). Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia. British Journal of Anaesthesia, 136(1), 326-332. https://doi.org/10.1016/j.bja.2025.10.025

Vancouver

Schiemann AH, Burling SM, Allen R, Bulger T, Machon RG, Perry M, et al. Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia. British Journal of Anaesthesia. 2026;136(1):326-332. doi:10.1016/j.bja.2025.10.025

BibTeX
@article{Schiemann2026,
  author = {Schiemann, Anja H and Burling, Sophie M and Allen, Remai and Bulger, Terasa and Machon, Roslyn G and Perry, Margaret and Street, Neil and van den Bersselaar, Luuk R and Stowell, Kathryn M},
  title = {Functional analysis of RYR1 variants in Australian and New Zealand patients at risk of susceptibility to malignant hyperthermia},
  journal = {British Journal of Anaesthesia},
  year = {2026},
  volume = {136},
  number = {1},
  pages = {326--332},
  doi = {10.1016/j.bja.2025.10.025}
}
Kostenlos starten →